Others have proposed that in CF there is failure of anti-inflammatory control mechanisms such as IL-10, NO, or transcription factors that compete with NF-κB for helicases, or there may be subtle abnormalities in both the pro- and anti-inflammatory arms of the cascade [reviewed in [4]]. The gene discussed is NFKB1; the disease is cystic fibrosis.